Literature DB >> 18036556

Complementary roles of the DRY motif and C-terminus tail of GPCRS for G protein coupling and beta-arrestin interaction.

Kyeong-Man Kim1, Marc G Caron.   

Abstract

beta-arrestin mediates the desensitization of GPCRs and acts as an adaptor molecule to recruit the receptor complex to clathrin-rich regions. Class-A GPCRs subsequently dissociate from beta-arrestin but class-B GPCRs internalize with beta-arrestin in the endocytic vesicles. Here the dopamine D(2) and D(3) receptors, which have similar structural features but different intracellular trafficking properties, were used in an attempt to better understand the structural requirements for the classification of GPCRs. The C-terminus tail of the vasopressin type-2 receptor was added to the ends of D(2)R and D(3)R to increase their affinity to beta-arrestin. A point mutation was introduced into the DRY motif to change their basal activation levels. Among a battery of constructs in which the C-terminus tail and/or DRY motif was altered, class-B behavior was observed with the constructs whose affinities for beta-arrestin were increased complementarily and their signaling was either maintained or regained. In conclusion, the DRY motif and C-terminal tail of the GPCRs determine complementarily their intracellular trafficking behavior by regulating the affinity to beta-arrestin and G protein coupling.

Mesh:

Substances:

Year:  2007        PMID: 18036556     DOI: 10.1016/j.bbrc.2007.11.055

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Novel dopamine D2 receptor signaling through proteins interacting with the third cytoplasmic loop.

Authors:  Kohji Fukunaga; Norifumi Shioda
Journal:  Mol Neurobiol       Date:  2011-12-20       Impact factor: 5.590

2.  β-arrestin2 plays permissive roles in the inhibitory activities of RGS9-2 on G protein-coupled receptors by maintaining RGS9-2 in the open conformation.

Authors:  Mei Zheng; Sang-Yoon Cheong; Chengchun Min; Mingli Jin; Dong-Im Cho; Kyeong-Man Kim
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

3.  Novel roles for β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors.

Authors:  C Min; M Zheng; X Zhang; M G Caron; K M Kim
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

4.  S-Nitrosylation of β-Arrestins Biases Receptor Signaling and Confers Ligand Independence.

Authors:  Hiroki Hayashi; Douglas T Hess; Rongli Zhang; Keiki Sugi; Huiyun Gao; Bea L Tan; Dawn E Bowles; Carmelo A Milano; Mukesh K Jain; Walter J Koch; Jonathan S Stamler
Journal:  Mol Cell       Date:  2018-05-03       Impact factor: 17.970

5.  An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.

Authors:  Hongxiang Lan; Martha M Teeter; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-26       Impact factor: 4.436

Review 6.  Minireview: the intimate link between calcium sensing receptor trafficking and signaling: implications for disorders of calcium homeostasis.

Authors:  Gerda E Breitwieser
Journal:  Mol Endocrinol       Date:  2012-06-28

7.  Post-synaptic density-95 (PSD-95) binding capacity of G-protein-coupled receptor 30 (GPR30), an estrogen receptor that can be identified in hippocampal dendritic spines.

Authors:  Keith T Akama; Louisa I Thompson; Teresa A Milner; Bruce S McEwen
Journal:  J Biol Chem       Date:  2013-01-08       Impact factor: 5.157

8.  A calcium-sensing receptor mutation causing hypocalcemia disrupts a transmembrane salt bridge to activate β-arrestin-biased signaling.

Authors:  Caroline M Gorvin; Valerie N Babinsky; Tomas Malinauskas; Peter H Nissen; Anders J Schou; Aylin C Hanyaloglu; Christian Siebold; E Yvonne Jones; Fadil M Hannan; Rajesh V Thakker
Journal:  Sci Signal       Date:  2018-02-20       Impact factor: 8.192

9.  PRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome.

Authors:  Wesley K Kroeze; Maria F Sassano; Xi-Ping Huang; Katherine Lansu; John D McCorvy; Patrick M Giguère; Noah Sciaky; Bryan L Roth
Journal:  Nat Struct Mol Biol       Date:  2015-04-20       Impact factor: 15.369

10.  Illuminating the life of GPCRs.

Authors:  Ilka Böhme; Annette G Beck-Sickinger
Journal:  Cell Commun Signal       Date:  2009-07-14       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.